Jonathan Siegrist, Ph.D. Executive Vice President of Research & Development & Chief Technology Officer, leads the company’s global R&D strategy, driving innovation and advancing next-generation diagnostic solutions. 

Jonathan brings over 15 years of leadership experience in the biotechnology and diagnostics industries, with a focus on molecular diagnostics, microfluidic platforms, and biomedical engineering. Before joining QuidelOrtho, Jonathan served as Chief Technology Officer and Head of Assay Research and Development at Cepheid.

Jonathan holds a PhD and Master of Science in Biomedical Engineering from the University of California, Irvine and a Bachelor of Science in Electrical Engineering from the University of California, Los Angeles. He has been recognized for his ability to lead complex, multidisciplinary teams while fostering a culture of creativity and innovation.